AltrixBio is pioneering a novel oral therapy, AJN003, designed to shift nutrient sensing for the treatment of type 2 diabetes and related metabolic diseases
AltrixBio is pioneering a novel oral therapy, AJN003, designed to shift nutrient sensing for the treatment of type 2 diabetes and related metabolic diseases. This therapy aims to provide improved glycemic control and weight loss without the need for surgery or injections.